Esophageal Neoplasms: all 1,631 studies
Page 8 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)Active, not recruitingNCT06143748Phase 2
- Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal CancerActive, not recruitingNCT06097078
- Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal CarcinomaCompletedNCT06060106
- Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old AgeCompletedNCT06048913Phase 2
- Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular PhenotypingStatus unknownNCT06048458
- Follow-up Strategy for Esophageal Cancer PatientsStatus unknownNCT06045715
- Esophageal Cancer Multimodal Prehabilitation StudyCompletedNCT06027515Not applicable
- Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal CancerCompletedNCT06015035Phase 2
- A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT06010303Phase 2
- A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.TerminatedNCT05977322Phase 1
- First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer PatientsCompletedNCT05964361Phase 1/2
- Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsActive, not recruitingNCT05945823Phase 2
- The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer PatientsCompletedNCT05944809Phase 2
- Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical InvestigationActive, not recruitingNCT05899985Not applicable
- Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal CancerWithdrawnNCT05898828Phase 1/2
- Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersActive, not recruitingNCT05891171Phase 1
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsCompletedNCT05864144Phase 1/2
- A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
- Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsCompletedNCT05858736Phase 1
- PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer PatientsCompletedNCT05855291Not applicable
- The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer PatientsCompletedNCT05855278Not applicable
- Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRTCompletedNCT05839002
- Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal CancerStatus unknownNCT05831488
- Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCCCompletedNCT05807542Phase 2
- A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsCompletedNCT05795595Phase 1/2
- Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at RiskCompletedNCT05787522
- A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal CancerTerminatedNCT05780736
- Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal CarcinomaStatus unknownNCT05777707Phase 1/2
- Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal CancerCompletedNCT05740852
- Monopolar and Bipolar in Esophageal ESDWithdrawnNCT05736705Not applicable
- High Flow Nasal Cannula After EsophagectomyStatus unknownNCT05718284Not applicable
- Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation TherapyActive, not recruitingNCT05717998
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
- Public's Intended Uptake and Views on Organization of Esophageal Cancer ScreeningStatus unknownNCT05690958
- Nordic Gastric and Esophageal Tumor StudyCompletedNCT05688761
- KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)CompletedNCT05680077
- Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal CancerActive, not recruitingNCT05667298Phase 1
- Assessment of Minimally Invasive Surgery for Esophageal CancerStatus unknownNCT05662644Not applicable
- Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus CancerStatus unknownNCT05626309Not applicable
- Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)Active, not recruitingNCT05621707Phase 2
- Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant SettingCompletedNCT05615129
- The PET-CT Predicting Response to Immunochemotherapy in Esophageal CancerStatus unknownNCT05615103
- Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CTCompletedNCT05611658
- A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid TumorsStatus unknownNCT05602792Phase 1/2
- Short-term Outcomes of ERAS Protocol in RAME for Esophageal CancerCompletedNCT05600335
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT05581004Phase 1
- RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDYStatus unknownNCT05570487
- Neoadjuvant Chemotherapy Compared With Surgery for Esophageal CarcinomaCompletedNCT05569668
- Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasActive, not recruitingNCT05565417Phase 1/2
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal CancerCompletedNCT05542680Not applicable
- Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaActive, not recruitingNCT05539430Phase 1
- Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05538195Phase 1/2
- The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)CompletedNCT05524844
- Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer SurgeryCompletedNCT05523960Not applicable
- Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic ResectionCompletedNCT05499195
- Computational Prediction and Experimental Validation of Esophageal Cancer Associated NeoantigensStatus unknownNCT05498168
- The Diagnostic Value of Nitrogen Element (N) in Esophagus CancerCompletedNCT05494359
- Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 StudyActive, not recruitingNCT05491616Phase 2
- The PLATON NetworkTerminatedNCT05489250
- Transnasal Esophagoscopy (TNE) Esophageal Cancer ScreeningTerminatedNCT05480891
- Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal JunctionActive, not recruitingNCT05480384Phase 2
- Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05476380Phase 2
- Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 ResectionStatus unknownNCT05460403
- Lung Ultrasound in the Early Detection of Postoperative Pulmonary Complications After EsophagectomyCompletedNCT05453760
- Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal CancerCompletedNCT05450484Phase 1
- Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsActive, not recruitingNCT05438420Phase 1/2
- FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)TerminatedNCT05432193Phase 1
- A Phase II Study of HR070803 in the Treatment of Advanced Esophageal CancerStatus unknownNCT05425472Phase 2
- Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of EsophagusStatus unknownNCT05424432Phase 2
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05415475Phase 1
- Investigating the Association Between Microbiota and Esophageal/Oropharyngeal CancerStatus unknownNCT05412628Not applicable
- Feasibility Study CORPPSCompletedNCT05406024
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerSuspendedNCT05400122Phase 1
- Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.Status unknownNCT05390684
- Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1CompletedNCT05383482Phase 1/2
- A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)CompletedNCT05342636Phase 1/2
- Conventional Oral Intake vs Delayed Oral Intake With Jejunostomy Feeding After Esophagectomy (JNS Study)CompletedNCT05318404Not applicable
- Anlotinib Retrospective Study for Esophageal CancerCompletedNCT05303740
- Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWithdrawnNCT05296005Phase 1
- VITAMin Insufficiency in Esophagogastric NeoplasmsCompletedNCT05281380Not applicable
- Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in VeteransStatus unknownNCT05210049Not applicable
- A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal CancerStatus unknownNCT05208775Not applicable
- Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic EsophagectomyStatus unknownNCT05199168Not applicable
- Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in ChinaCompletedNCT05194371
- AN0025 and Chemoradiotherapy Combination in Esophageal CancerSuspendedNCT05191667Phase 1
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
- Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.Active, not recruitingNCT05176002Phase 1/2
- Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal CancerStatus unknownNCT05174156Phase 2
- Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal CarcinomaStatus unknownNCT05174117Not applicable
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersActive, not recruitingNCT05152147Phase 3
- the Effect of Acupoint Application Combined With Ear Acupoint Embedding in Patients After Esophageal Cancer SurgeryStatus unknownNCT05151068Not applicable
- To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without SurgeryActive, not recruitingNCT05145647Not applicable
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)Active, not recruitingNCT05094336Phase 1/2
- GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric CancerCompletedNCT05088304
- Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First ExperiencesCompletedNCT05069766Not applicable